Panagora Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Panagora Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,426	Closed	-$43K	–	2594
2021 Q2	$43K	Buy	4,426 +1,050	+31%	+$8.36K	﹤0.01%	2090
2021 Q1	$28K	Hold	3,376	–	–	﹤0.01%	2273
2020 Q4	$23K	Buy	+3,376	New	+$27.1K	﹤0.01%	2177
2016 Q1	–	Sell	-10,528	Closed	-$92K	–	2356
2015 Q4	$92K	Buy	10,528 +4,566	+77%	+$38.5K	﹤0.01%	1820
2015 Q3	$50K	Sell	5,962 -14,679	-71%	-$234K	﹤0.01%	1995
2015 Q2	$364K	Sell	20,641 -17,382	-46%	-$223K	﹤0.01%	1451
2015 Q1	$440K	Buy	+38,023	New	+$440K	﹤0.01%	1369
2014 Q2	–	Sell	-30,877	Closed	-$396K	–	2403
2014 Q1	$396K	Buy	+30,877	New	+$342K	﹤0.01%	1509

Other funds holding SRNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Panagora Asset Management's SRNE Position: Q3 2021 in Review

Panagora Asset Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2021, closing a stake of 4,426 shares — an estimated $43K sold.

Panagora Asset Management first reported a position in SRNE in Q1 2014 and held it in 8 quarters. The position peaked at $440K in Q1 2015. 220 funds tracked by Wall St. Rank hold SRNE as of Q3 2021.

Panagora Asset Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 4,426 Sorrento Therapeutics, Inc. shares in Q3 2021, an estimated $43K.
Panagora Asset Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and held it in 8 quarters.
Panagora Asset Management's Sorrento Therapeutics, Inc. position peaked at $440K in Q1 2015.
220 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.